This job has expired

You will need to login before you can apply for a job.

Associate Scientist or Scientist I, Primary Cell Editing

Mammoth Biosciences
Brisbane, CA
Start date
Jul 28, 2022

View more

Clinical, Medical Writing, Science/R&D, Biotechnology
Required Education
Bachelors Degree
Position Type
Full time
Biotech Bay
You need to sign in or create an account to save a job.

Job Details

We are currently seeking an Associate Scientist or Scientist I, Primary Cell Editing who will be conducting gene editing translational research within the growing Blood Disorders group at Mammoth Biosciences. The successful candidate will make significant contributions to several projects within Mammoth’s early-stage therapeutics pipeline. Specifically, the candidate will culture and characterize primary cells using a variety of established methods. The candidate will receive hands-on training in the use of Mammoth’s proprietary CRISPR nuclease systems for therapeutic gene editing.
  • Gene edit primary cells using Mammoth CRISPR systems
  • Maintain primary cells in tissue culture
  • Characterize edited cells by genomic and biochemical techniques including ddPCR/qPCR, western blot, and flow cytometry

  • Degree in Biology, Chemistry, Biochemistry, Biotechnology or related discipline
  • BS with 4+ years of postgraduate research experience, Master's with 2+ years, or PhD with a minimum of 1 year experience
  • At least one year of industry research experience
  • Experience with standard molecular biology techniques including PCR, ddPCR or qPCR
  • Experience with standard molecular phenotyping techniques including western blot, ELISA or flow cytometry

  • Experience in gene editing
  • Experience in culture of primary human cells
  • Experience in next-generation sequencing library preparation
  • A foundation in experimental documentation and data presentation
  • Excellent oral and written communication skills

  • Company-paid health/vision/dental benefits
  • Unlimited vacation and generous sick time
  • Company-sponsored meals and snacks
  • Wellness, caregiver and ergonomics benefits
  • 401(k) with company matching

Mammoth Biosciences is harnessing the diversity of life to power the next generation of CRISPR products. Through the discovery and engineering of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Mammoth aims to develop permanent genetic cures through best-in-class in vivo and ex vivo therapies and to democratize disease detection with on-demand diagnostics. Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in the San Francisco Bay Area, Mammoth Biosciences is co-founded by CRISPR pioneer and Nobel Laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Redmile Group, Foresite Capital, Senator Investment Group, Sixth Street, Decheng, Mayfield, NFX, and 8VC, along with leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.

Our small-size proteins, such as Cas14 and CasPhi, are poised to transform disease treatment enabling novel editing approaches and delivery options that are difficult to achieve or not even possible with previously described CRISPR-Cas systems. Our teams are responsible for discovering and engineering novel CRISPR systems, establishing CRISPR-based diagnostics, and translating our unique CRISPR technology into therapeutic treatments with the ultimate goal of cures for indications with high medical need.

It is our policy and intent to provide equal opportunity to all persons without regard to race, color, religion, political affiliation, sex/gender (including gender expression/identity, pregnancy, childbirth and related medical conditions), marital status, registered domestic partner status, sexual orientation, age, ancestry, national origin, veteran status, disability, medical condition, genetic characteristics, and/or any other basis protected by law. This policy covers all facets of employment including, but not limited to: recruitment, selection, placement, promotions, transfers, demotions, terminations, training, and compensation.

Mammoth Biosciences requires that all employees be vaccinated against COVID-19 as a condition of at-will employment, with exceptions for medical or religious reasons in compliance with local, state, and federal law. 


Mammoth Biosciences is harnessing the diversity of nature to power the next generation of CRISPR products. Through its discovery of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. With a distinguished team including co-founder and CRISPR-Cas genome editing co-inventor Jennifer Doudna, Mammoth is addressing challenges across healthcare, agriculture, environmental monitoring, biodefense, and more.

Facebook  Twitter  Instagram

Find Us
(650) 294-8583
South San Francisco
United States
You need to sign in or create an account to save a job.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert